News from pdl biopharma, inc. A wide array of domestic and global news stories; news topics include politics/government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle.

Latest

Dec 14, 2020, 08:30 ET PDL BioPharma Enters into $51.4 Million Capital Provision Agreement with Epps Investments LLC Regarding PDL's Previously Announced Settlement Agreement with Wellstat

PDL BioPharma, Inc. ("PDL" or the "Company") (Nasdaq: PDLI) announces it has entered into a Capital Provision Agreement (the "Agreement") with Epps...

Dec 08, 2020, 16:05 ET PDL Announces Timeline for Voluntarily Delisting from Nasdaq

PDL BioPharma, Inc. ("PDL" or the "Company") (Nasdaq: PDLI) today announced that it has formally notified The Nasdaq Stock Market, Inc. of its intent ...

Nov 11, 2020, 16:05 ET PDL BioPharma Reports 2020 Third Quarter Financial Results and Sets Date To File a Certificate of Dissolution

PDL BioPharma, Inc. ("PDL" or "the Company") (Nasdaq: PDLI) reports financial results for the three and nine months ended September 30, 2020 and...

Nov 06, 2020, 17:26 ET PDL BioPharma Reschedules Third Quarter 2020 Financial Results and Business Update

PDL BioPharma, Inc. ("PDL" or "the Company") (Nasdaq: PDLI) announces it has rescheduled the date for announcing third quarter 2020 financial results ...

Oct 29, 2020, 08:00 ET PDL BioPharma to Announce Third Quarter 2020 Financial Results and Provide a Business Update on November 9, 2020

PDL BioPharma, Inc. ("PDL" or "the Company") (Nasdaq: PDLI) announces that it will release its third quarter 2020 financial results for the period...

Oct 02, 2020, 08:30 ET PDL BioPharma Completes Spin-Off of LENSAR

PDL BioPharma, Inc. ("PDL" or the "Company") (Nasdaq: PDLI) today announced that it has completed the previously announced spin-off of its...

Sep 10, 2020, 08:30 ET PDL BioPharma to Complete Spin-Off of LENSAR, Inc. on October 1, 2020

PDL BioPharma, Inc. ("PDL" or the "Company") (Nasdaq: PDLI) announced that its Board of Directors has approved the separation of LENSAR, Inc....

Sep 09, 2020, 08:30 ET PDL BioPharma Completes Divestiture of the Noden Pharmaceutical Business to Stanley Capital

PDL BioPharma, Inc. ("PDL" or the "Company") (Nasdaq: PDLI) announces the closing of the sale of its wholly owned subsidiaries Noden Pharma DAC and...

Aug 31, 2020, 09:00 ET PDL BioPharma Announces Sale of Kybella®, Zalviso® and Coflex® Royalties to SWK Holdings Corporation

PDL BioPharma, Inc. ("PDL" or the "Company") (Nasdaq: PDLI) announces the signing and closing of a definitive agreement for the sale of three royalty ...

Aug 28, 2020, 08:30 ET PDL BioPharma Announces Offer to Purchase Convertible Notes Due 2021 and 2024

PDL BioPharma, Inc. ("PDL" or the "Company") (Nasdaq: PDLI) today announced that holders of its 2.75% Convertible Senior Notes due in December 2021...

Aug 26, 2020, 09:00 ET PDL BioPharma Announces Filing of a Form 10 Registration Statement with the Securities and Exchange Commission for a Potential Spin-off of LENSAR to PDL's Stockholders

PDL BioPharma, Inc. ("PDL" or the "Company") (Nasdaq: PDLI) announces that its majority owned medical device subsidiary, LENSAR, Inc. ("LENSAR"), has ...

Aug 12, 2020, 08:30 ET PDL BioPharma Enters Into Settlement Agreement with Wellstat

PDL BioPharma, Inc. ("PDL" or the "Company") (Nasdaq: PDLI) announces it has entered into a settlement agreement (the "Settlement Agreement") with...

Aug 06, 2020, 16:05 ET PDL BioPharma Reports 2020 Second Quarter Financial Results

PDL BioPharma, Inc. ("PDL" or "the Company") (Nasdaq: PDLI) reports financial results for the three and six months ended June 30, 2020 and provides...

Jul 30, 2020, 16:05 ET PDL BioPharma to Announce Second Quarter 2020 Financial Results on August 6, 2020

PDL BioPharma, Inc. ("PDL" or "the Company") (Nasdaq: PDLI) announces that it will release its second quarter 2020 financial results for the period...

Jul 30, 2020, 08:30 ET PDL BioPharma Enters Into Agreement for the Divestiture of the Noden Pharmaceutical Business to Stanley Capital

PDL BioPharma, Inc. ("PDL" or the "Company") (Nasdaq: PDLI) announces the signing of a definitive agreement for the sale of 100% of the outstanding...

May 21, 2020, 16:05 ET PDL BioPharma Completes Distribution of Evofem Biosciences Common Stock to PDL Stockholders

PDL BioPharma, Inc. ("PDL" or the "Company") (Nasdaq: PDLI) announces that it has completed its previously announced distribution of all of the...

May 18, 2020, 16:05 ET PDL BioPharma Declares Distribution Ratio for Dividend of Evofem Biosciences Common Stock to PDL Stockholders

PDL BioPharma, Inc. ("PDL" or the "Company") (Nasdaq: PDLI) announces the final distribution ratio for the previously announced distribution of all...

May 07, 2020, 16:05 ET PDL BioPharma Reports 2020 First Quarter Financial Results

PDL BioPharma, Inc. ("PDL" or "the Company") (Nasdaq: PDLI) reports financial results for the three months ended March 31, 2020 and provides a...

May 05, 2020, 16:05 ET PDL BioPharma Declares Dividend of Evofem Biosciences Common Stock to PDL Stockholders

PDL BioPharma, Inc. ("PDL" or "the Company") (Nasdaq: PDLI) announces that the Company's Board of Directors has approved a distribution of all of the ...

Apr 30, 2020, 08:30 ET PDL BioPharma to Announce First Quarter 2020 Financial Results on May 7, 2020

PDL BioPharma, Inc. ("PDL" or "the Company") (Nasdaq: PDLI) announces that it will release its first quarter 2020 financial results for the period...

Mar 11, 2020, 16:05 ET PDL BioPharma Reports 2019 Fourth Quarter and Full Year Financial Results and Announces Plan to Dissolve the Company by Year-End 2020

PDL BioPharma, Inc. ("PDL" or "the Company") (Nasdaq: PDLI) provides an update on its strategic plans and reports financial results for the three and ...

Mar 09, 2020, 16:05 ET PDL BioPharma Announces Appointment of Edward A. Imbrogno as Vice President and Chief Financial Officer

PDL BioPharma, Inc. ("PDL" or the "Company") (Nasdaq: PDLI) today announced the appointment of Edward A. Imbrogno as the Company's Vice President and ...

Mar 04, 2020, 08:30 ET PDL BioPharma to Announce 2019 Fourth Quarter and Full Year Financial Results on March 11, 2020

PDL BioPharma, Inc. ("PDL" or "the Company") (Nasdaq: PDLI) announces that it will release its 2019 fourth quarter and full year financial results...

Feb 28, 2020, 08:00 ET PDL BioPharma Enters into Cooperation Agreement with Engine Capital

PDL BioPharma, Inc. ("PDL" or the "Company") (Nasdaq: PDLI) today announced it has entered into a cooperation agreement with Engine Capital...

Feb 25, 2020, 08:30 ET PDL BioPharma to Participate in the Cowen and Company 40th Annual Health Care Conference

PDL BioPharma, Inc. ("PDL" or the "Company") (Nasdaq: PDLI) announces that Dominique Monnet, PDL's president and chief executive officer, will...